News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
79,316 Results
Type
Article (2049)
Company Profile (2)
Press Release (77265)
Section
Business (23330)
Career Advice (10)
Deals (4847)
Drug Development (9640)
FDA (2175)
Job Trends (1122)
News (41050)
Policy (3898)
Tag
Academia (106)
Accelerated approval (2)
Allergies (10)
Alliances (8432)
ALS (15)
Alzheimer's disease (179)
Antibody-drug conjugate (ADC) (24)
Approvals (2222)
Artificial intelligence (45)
Autoimmune disease (5)
Automation (4)
Bankruptcy (8)
Best Places to Work (1048)
Biosimilars (27)
Biotechnology (5)
Bladder cancer (26)
Brain cancer (4)
Breast cancer (91)
Cancer (587)
Cardiovascular disease (24)
Career advice (10)
CAR-T (13)
Cell therapy (58)
Cervical cancer (6)
Clinical research (8873)
Collaboration (182)
Compensation (70)
Complete response letters (2)
COVID-19 (234)
CRISPR (5)
C-suite (28)
Cystic fibrosis (12)
Data (537)
Depression (4)
Diabetes (40)
Diagnostics (788)
Digital health (1)
Drug discovery (20)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (9552)
Events (8562)
Executive appointments (104)
FDA (2524)
Featured Employer (1)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (170)
Gene editing (11)
Generative AI (1)
Gene therapy (48)
GLP-1 (79)
Government (262)
Grass and pollen (2)
Guidances (13)
Healthcare (1279)
Huntington's disease (2)
IgA nephropathy (5)
Immunology and inflammation (8)
Indications (7)
Infectious disease (259)
Inflammatory bowel disease (23)
Influenza (9)
Intellectual property (26)
IPO (1871)
Job creations (244)
Job search strategy (10)
Kidney cancer (3)
Layoffs (6)
Legal (970)
Liver cancer (23)
Lung cancer (90)
Lymphoma (35)
Manufacturing (48)
MASH (18)
Medical device (1304)
Medtech (1305)
Mergers & acquisitions (3140)
Metabolic disorders (98)
Multiple sclerosis (16)
NASH (5)
Neurodegenerative disease (18)
Neuroscience (278)
NextGen: Class of 2025 (254)
Non-profit (76)
Northern California (448)
Obesity (36)
Opinion (1)
Ovarian cancer (16)
Pain (12)
Pancreatic cancer (16)
Parkinson's disease (35)
Partnered (2)
Patents (42)
Patient recruitment (22)
Peanut (3)
People (5251)
Pharmaceutical (3)
Phase I (2314)
Phase II (3619)
Phase III (3539)
Pipeline (262)
Postmarket research (339)
Preclinical (791)
Press Release (2)
Prostate cancer (29)
Radiopharmaceuticals (26)
Rare diseases (63)
Real estate (606)
Regulatory (3051)
Reports (7)
Research institute (111)
Rett syndrome (4)
RSV (9)
Schizophrenia (12)
Series A (29)
Series B (23)
Service/supplier (1)
Sickle cell disease (10)
Southern California (427)
Spinal muscular atrophy (13)
Startups (427)
Stomach cancer (1)
Supply chain (11)
United States (4003)
Vaccines (58)
Venture capitalists (2)
Weight loss (6)
Women's health (5)
Date
Today (5)
Last 7 days (102)
Last 30 days (610)
Last 365 days (6535)
2025 (2170)
2024 (5537)
2023 (4545)
2022 (7805)
2021 (7127)
2020 (6534)
2019 (4285)
2018 (3317)
2017 (3897)
2016 (3442)
2015 (4330)
2014 (3235)
2013 (2717)
2012 (2876)
2011 (3019)
2010 (2781)
Location
Africa (82)
Alabama (2)
Arizona (10)
Arkansas (1)
Asia (21682)
Australia (2484)
California (1126)
Canada (363)
China (192)
Colorado (48)
Connecticut (71)
Delaware (62)
Europe (14567)
Florida (84)
Georgia (31)
Idaho (1)
Illinois (83)
India (11)
Indiana (15)
Iowa (3)
Japan (98)
Kansas (5)
Louisiana (1)
Maine (5)
Maryland (132)
Massachusetts (913)
Michigan (16)
Minnesota (59)
Missouri (21)
Nebraska (2)
Nevada (8)
New Hampshire (4)
New Jersey (398)
New Mexico (1)
New York (331)
North Carolina (108)
North Dakota (1)
Northern California (448)
Ohio (23)
Oregon (5)
Pennsylvania (146)
Puerto Rico (1)
Rhode Island (2)
South America (114)
South Carolina (1)
Southern California (427)
Tennessee (14)
Texas (177)
Utah (20)
Virginia (57)
Washington D.C. (7)
Washington State (91)
Wisconsin (22)
79,316 Results for "f2g ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Drug Development
F2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at Trends in Medical Mycology (TIMM) 2023 Demonstrating Positive Therapeutic Responses in Patients with Invasive Fungal Infections Treated with Oral Olorofim
F2G Ltd. and Shionogi & Co., Ltd., announced full results from the pivotal Phase 2b open-label study of olorofim in patients with proven invasive fungal infections or probable pulmonary invasive aspergillosis and limited or no treatment options.
October 21, 2023
·
10 min read
Press Releases
Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOL™ PF for the Treatment of Presbyopia
April 8, 2025
·
5 min read
Press Releases
Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events
March 28, 2025
·
3 min read
Press Releases
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
April 3, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer
March 11, 2025
·
3 min read
F2G to Present at Biotech Showcase™ 2023
F2G Ltd. today announced that the Company’s chief executive officer, Francesco Lavino will provide a corporate overview at Biotech Showcase™ 2023 taking place in San Francisco, California, from January 9-11, 2023.
January 5, 2023
·
4 min read
Press Releases
Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer
April 1, 2025
·
4 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
F2G Receives Complete Response Letter from FDA for New Drug Application for Olorofim for The Treatment of Invasive Fungal Infections; Plans Resubmission With Additional Data and Analyses
F2G Ltd. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for olorofim, an investigational antifungal, for the treatment of invasive fungal infections in patients who have limited or no treatment options.
June 19, 2023
·
5 min read
1 of 7,932
Next
